A Retrospective Observational Study of Hemoglobin Levels in Patients With Renal Anemia Treated With Mircera (Methoxy Polyethylene Glycol-Epoetin Beta)
NCT01379963 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 780
Last updated 2017-07-13
Summary
This retrospective observational study will evaluate the hemoglobin levels in patients with renal anemia over 6 months treatment with Mircera (methoxy polyethylene glycol-epoetin beta).
Conditions
- Anemia, Kidney Disease, Chronic
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Clinical Trials · Hoffmann-La Roche
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-04-30
- Primary Completion
- 2011-02-28
- Completion
- 2011-02-28
Countries
- Greece
Study Locations
More Related Trials
-
A Non-Interventional Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Patients With Chronic Kidney Disease Not on Dialysis
NCT01892202 ·Status: NO_LONGER_AVAILABLE
-
OPTIMA: An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Participants With Chronic Kidney Disease Stages 3 and 4 Not on Dialysis
NCT01902628 ·Status: COMPLETED
-
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
NCT00077597 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Intravenous Mircera (C.E.R.A or Methoxy Polyethylene Glycol-epoetin Beta) for the Maintenance Treatment of Hemodialysis Participants With Chronic Renal Anemia
NCT00605293 ·Status: COMPLETED ·Phase: PHASE3
-
An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Chronic Kidney Disease Patients on Dialysis With Renal Anemia
NCT01677767 ·Status: COMPLETED
-
A Study of Mircera in Renal Anemia Among Filipino Chronic Kidney Disease Patients
NCT00922610 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
NCT00077766 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess All-Cause Mortality and Cardiovascular Morbidity in Participants With Chronic Kidney Disease (CKD) on Dialysis and Those Not on Renal Replacement Therapy Receiving Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) or Reference Erythropoietin Stimulating Agents (ESAs)
NCT00773513 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
NCT00413894 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Monthly Intravenous C.E.R.A. (Mircera) in Hemodialysis Participants With Chronic Renal Anemia
NCT00699348 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Subcutaneous Mircera for the Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease Not on Dialysis
NCT00642967 ·Status: COMPLETED ·Phase: PHASE3
-
An Observational Study of Methoxy Polyethylene Glycol-epoetin Beta in Participants With a Kidney Transplant
NCT02538107 ·Status: COMPLETED
-
A Study of Once Monthly Subcutaneous Mircera in Dialysis Patients With Chronic Renal Anemia
NCT00882713 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Subcutaneous Mircera in Participants With Chronic Kidney Disease Not Treated With ESA or on Dialysis
NCT00559637 ·Status: COMPLETED ·Phase: PHASE3
-
An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Stage III-IV Chronic Kidney Disease Patients Not on Dialysis With Renal Anemia
NCT01695746 ·Status: COMPLETED
-
A Study of Once-Monthly Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia.
NCT00560547 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Participants With Chronic Kidney Disease Not on Dialysis
NCT00559273 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Once Monthly Subcutaneous Mircera in Patients With Chronic Renal Anemia Not on Dialysis
NCT00922116 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of The Effect of Altitude on Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) Dose Requirements in Participants With Chronic Renal Anemia in Pre-Dialysis or Dialysis
NCT01519947 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Monthly Subcutaneous or Intravenous Mircera in Dialysis Patients With Chronic Renal Anaemia
NCT01156363 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Monthly Subcutaneous (SC) Mircera for Maintenance Treatment of Participants With Chronic Kidney Disease on Peritoneal Dialysis
NCT00737477 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Determine Optimum Intravenous Starting Dose of MIRCERA for Treatment of Pediatric Participants With Anemia and Chronic Kidney Disease on Hemodialysis
NCT00717366 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
NCT00442702 ·Status: COMPLETED ·Phase: PHASE3
-
An Observational Study of Mircera in Renal Anemia Correction In Dialysed Patients During Daily Clinical Practice
NCT01690455 ·Status: COMPLETED
-
A Study of Two-Weekly Intravenous Mircera for the Treatment of Dialysis Patients With Chronic Renal Anemia Not Receiving ESA Therapy.
NCT00737711 ·Status: COMPLETED ·Phase: PHASE4